Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?

James Kenneth Byrd, Robert L. Ferris

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Given the potential for long-term toxicities from concurrent chemoradiation, there is great interest in surgery as a primary treatment modality for head and neck cancers, particularly in the younger HPV-positive oropharyngeal cancer patient. Transoral robotic surgery (TORS) has proven to be an effective technique to safely treat oropharyngeal and select supraglottic tumors surgically. Sound, traditional surgical principles are employed using improved endoscopic visualization and precise instrumentation to perform oncologic surgery without the morbidity of transmandibular or transcervical approaches. Although level 1 evidence prospective clinical trials are currently underway for TORS, the literature supports its safety and efficacy based on numerous studies. Currently, prospective randomized trials are underway to provide better evidence for or against TORS in oropharyngeal cancer. Patient selection based on comorbidities, anatomy, and available pathological data is critical in choosing patients for TORS.

Original languageEnglish (US)
Article number29
JournalCurrent Treatment Options in Oncology
Volume17
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Robotics
Head and Neck Neoplasms
Oropharyngeal Neoplasms
Therapeutics
Patient Selection
Comorbidity
Anatomy
Clinical Trials
Morbidity
Safety
Neoplasms

Keywords

  • Head and neck cancer
  • Minimally invasive surgery
  • Oropharyngeal cancer
  • TORS
  • Transoral robotic surgery

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer? / Byrd, James Kenneth; Ferris, Robert L.

In: Current Treatment Options in Oncology, Vol. 17, No. 6, 29, 01.06.2016.

Research output: Contribution to journalReview article

@article{febdc41dbaaa489a8eaba5666b49edcc,
title = "Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?",
abstract = "Given the potential for long-term toxicities from concurrent chemoradiation, there is great interest in surgery as a primary treatment modality for head and neck cancers, particularly in the younger HPV-positive oropharyngeal cancer patient. Transoral robotic surgery (TORS) has proven to be an effective technique to safely treat oropharyngeal and select supraglottic tumors surgically. Sound, traditional surgical principles are employed using improved endoscopic visualization and precise instrumentation to perform oncologic surgery without the morbidity of transmandibular or transcervical approaches. Although level 1 evidence prospective clinical trials are currently underway for TORS, the literature supports its safety and efficacy based on numerous studies. Currently, prospective randomized trials are underway to provide better evidence for or against TORS in oropharyngeal cancer. Patient selection based on comorbidities, anatomy, and available pathological data is critical in choosing patients for TORS.",
keywords = "Head and neck cancer, Minimally invasive surgery, Oropharyngeal cancer, TORS, Transoral robotic surgery",
author = "Byrd, {James Kenneth} and Ferris, {Robert L.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1007/s11864-016-0405-5",
language = "English (US)",
volume = "17",
journal = "Current Treatment Options in Oncology",
issn = "1527-2729",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?

AU - Byrd, James Kenneth

AU - Ferris, Robert L.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Given the potential for long-term toxicities from concurrent chemoradiation, there is great interest in surgery as a primary treatment modality for head and neck cancers, particularly in the younger HPV-positive oropharyngeal cancer patient. Transoral robotic surgery (TORS) has proven to be an effective technique to safely treat oropharyngeal and select supraglottic tumors surgically. Sound, traditional surgical principles are employed using improved endoscopic visualization and precise instrumentation to perform oncologic surgery without the morbidity of transmandibular or transcervical approaches. Although level 1 evidence prospective clinical trials are currently underway for TORS, the literature supports its safety and efficacy based on numerous studies. Currently, prospective randomized trials are underway to provide better evidence for or against TORS in oropharyngeal cancer. Patient selection based on comorbidities, anatomy, and available pathological data is critical in choosing patients for TORS.

AB - Given the potential for long-term toxicities from concurrent chemoradiation, there is great interest in surgery as a primary treatment modality for head and neck cancers, particularly in the younger HPV-positive oropharyngeal cancer patient. Transoral robotic surgery (TORS) has proven to be an effective technique to safely treat oropharyngeal and select supraglottic tumors surgically. Sound, traditional surgical principles are employed using improved endoscopic visualization and precise instrumentation to perform oncologic surgery without the morbidity of transmandibular or transcervical approaches. Although level 1 evidence prospective clinical trials are currently underway for TORS, the literature supports its safety and efficacy based on numerous studies. Currently, prospective randomized trials are underway to provide better evidence for or against TORS in oropharyngeal cancer. Patient selection based on comorbidities, anatomy, and available pathological data is critical in choosing patients for TORS.

KW - Head and neck cancer

KW - Minimally invasive surgery

KW - Oropharyngeal cancer

KW - TORS

KW - Transoral robotic surgery

UR - http://www.scopus.com/inward/record.url?scp=84964758090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964758090&partnerID=8YFLogxK

U2 - 10.1007/s11864-016-0405-5

DO - 10.1007/s11864-016-0405-5

M3 - Review article

VL - 17

JO - Current Treatment Options in Oncology

JF - Current Treatment Options in Oncology

SN - 1527-2729

IS - 6

M1 - 29

ER -